back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-06-13 21:10 Tx date 2024-06-11 |
$AIAI
Netramark Holdings Inc. |
Jaitly, Sheetal
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$43,750
+125,000 vol $0.35 each |
210,000 | |
| Filed 2023-08-28 19:33 Tx date 2023-08-24 |
$AIAI
Netramark Holdings Inc. (formerly Nurosene Health Inc.) |
Jaitly, Sheetal
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-62,500 vol |
0 | |
| Filed 2023-08-28 19:32 Tx date 2023-08-24 |
$AIAI
Netramark Holdings Inc. (formerly Nurosene Health Inc.) |
Jaitly, Sheetal
4 - Director of Issuer
Holder: Jaitly 2020 Family Trust (Indirect Ownership)
|
Warrants
54 - Exercise of warrants
|
-31,250 vol |
268,750 | |
| Filed 2023-08-28 19:31 Tx date 2023-08-24 |
$AIAI
Netramark Holdings Inc. (formerly Nurosene Health Inc.) |
Jaitly, Sheetal
4 - Director of Issuer
Holder: To The Moon LLC (Indirect Ownership)
|
Common Shares
54 - Exercise of warrants
|
$37,500
+62,500 vol $0.60 each |
62,500 | |
| Filed 2023-08-28 19:30 Tx date 2020-06-01 |
$AIAI
Netramark Holdings Inc. (formerly Nurosene Health Inc.) |
Jaitly, Sheetal
4 - Director of Issuer
Holder: To The Moon LLC (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-08-28 19:30 Tx date 2023-08-24 |
$AIAI
Netramark Holdings Inc. (formerly Nurosene Health Inc.) |
Jaitly, Sheetal
4 - Director of Issuer
Holder: Jaitly 2020 Family Trust (Indirect Ownership)
|
Common Shares
54 - Exercise of warrants
|
$12,500
+31,250 vol $0.40 each |
331,250 | |
| Filed 2023-06-21 21:56 Tx date 2023-06-20 |
$AIAI
Netramark Holdings Inc. (formerly Nurosene Health Inc.) |
Jaitly, Sheetal
4 - Director of Issuer
Direct Ownership
|
Common Shares Restricted Share Units
56 - Grant of rights
|
+100,000 vol |
100,000 | |
| Filed 2023-06-21 21:55 Tx date 2020-06-01 |
$AIAI
Netramark Holdings Inc. (formerly Nurosene Health Inc.) |
Jaitly, Sheetal
4 - Director of Issuer
Direct Ownership
|
Common Shares Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-06-21 21:55 Tx date 2023-06-20 |
$AIAI
Netramark Holdings Inc. (formerly Nurosene Health Inc.) |
Jaitly, Sheetal
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$9,500
+25,000 vol $0.38 each |
85,000 | |
| Filed 2022-11-01 21:18 Tx date 2022-10-12 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Jaitly, Sheetal
4 - Director of Issuer
Holder: Jaitly 2020 Family Trust (Indirect Ownership)
|
Warrants
30 - Acquisition or disposition under a purchase/ownership plan
|
$120,000
+300,000 vol $0.40 each |
300,000 | |
| Filed 2022-11-01 21:17 Tx date 2020-06-01 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Jaitly, Sheetal
4 - Director of Issuer
Holder: Jaitly 2020 Family Trust (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-11-01 21:16 Tx date 2022-10-12 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Jaitly, Sheetal
4 - Director of Issuer
Holder: Jaitly 2020 Family Trust (Indirect Ownership)
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$75,000
+300,000 vol $0.25 each |
300,000 | |
| Filed 2022-11-01 21:16 Tx date 2020-06-01 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Jaitly, Sheetal
4 - Director of Issuer
Holder: Jaitly 2020 Family Trust (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-06-14 13:55 Tx date 2022-06-08 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Jaitly, Sheetal
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+62,500 vol |
62,500 | |
| Filed 2022-06-14 13:54 Tx date 2022-06-08 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Jaitly, Sheetal
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$50,000
+125,000 vol $0.40 each |
125,000 | |
| Filed 2022-06-14 13:54 Tx date 2020-06-01 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Jaitly, Sheetal
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-06-14 13:53 Tx date 2020-06-01 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Jaitly, Sheetal
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-06-11 15:12 Tx date 2021-06-08 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Jaitly, Sheetal
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$54,000
+60,000 vol $0.90 each |
60,000 | |
| Filed 2021-06-11 15:10 Tx date 2020-06-01 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Jaitly, Sheetal
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|